IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18
Chen, Wen1,2; Zhang, Xun1; Molijn, Anco3; Jenkins, David4; Shi, Ju-Fang1; Quint, Wim3; Schmidt, Johannes E.5; Wang, Ping6; Liu, Yu-Ling7; Li, Lian-Kun8; Shi, Hong9; Liu, Ji-Hong10; Xie, Xing11; Niyazi, Mayinuer12; Yang, Pei13; Wei, Li-Hui14; Li, Long-Yu15; Li, Jie16; Liu, Jin-Feng17; Zhou, Qi18; Hong, Ying19; Li, Li20; Li, Qing21; Zhou, Hong-Lin22; Bian, Mei-Lu23; Chen, Jing24; Qiao, You-Lin1; Smith, Jennifer S.25
关键词Human Papillomavirus Cervical Cancer High-grade Squamous Intraepithelial Lesions Epidemiology China
刊名CANCER CAUSES & CONTROL
2009-11-01
DOI10.1007/s10552-009-9422-z
20期:9页:1705-1713
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Public, Environmental & Occupational Health
研究领域[WOS]Oncology ; Public, Environmental & Occupational Health
关键词[WOS]RISK-FACTORS ; WOMEN ; METAANALYSIS ; NEOPLASIA ; INFECTION ; CARCINOMA ; PROVINCE
英文摘要

Prophylactic vaccination against HPV 16 and 18 has the potential for effective prevention of high-grade precancer (cervical intraepithelial neoplasia [CIN)] 2/3) and ICC caused by these viruses (globally 50 and 70%, respectively) when employed in women prior to starting sexual activity. To provide data for decisions on HPV vaccination in China, we determined HPV type-distribution in ICC and CIN 2/3 from women of different regions within China. A multicenter study was conducted by randomized sampling of paraffin blocks of 664 ICC (630 squamous cell carcinoma [SCC]; 34 adenocarcinoma [ADC]), 569 CIN 2/3 cases from seven regions of China. Histological diagnosis was confirmed in 1,233 cases by consensus review. HPV DNA was detected using the SPF10 LiPA25 version 1 assay. HPV prevalence was 97.6% in SCC, 85.3% in adenocarcinoma, and 98.9% in CIN 2/3. HPV 16 (76.7%) and HPV 18 (7.8%) were the most common, together accounting for 84.5% of SCC, followed by HPV 31 (3.2%), HPV 52 (2.2%), and HPV 58 (2.2%). HPV positivity in SCC did not differ notably by region. However, SCC cases from women <= 34 years had higher HPV 16 positivity than women over 50 years, among whom HPV 52, 58, and 39 were more common. HPV 16 and 18 were under-represented, whereas HPV 31, 52, and 58 were over-represented in CIN2/3 compared to SCC. The potential impact of vaccines against oncogenic HPV types 16 and 18 is estimated to be high (84.5%) against total SCC. These data are critical for China′s future evaluation of the cost-effectiveness of current cervical cancer vaccines and of HPV-based screening guidelines.

语种英语
WOS记录号WOS:000271198400018
资助机构GlaxoSmithKline Biologicals and Cancer Foundation of China
引用统计
被引频次:49[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/55792
专题北京大学第二临床医学院
作者单位1.Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China
2.DDL Diagnost Lab, Voorburg, Netherlands
3.Zhengzhou Univ, Affiliated Hosp 2, Zhengzhou, Peoples R China
4.Liaoning Canc Hosp, Shenyang, Peoples R China
5.Univ Nottingham, Nottingham NG7 2RD, England
6.GlaxoSmithKline Biol, Rixensart, Belgium
7.Shaanxi Canc Hosp, Xian, Peoples R China
8.Chinese Acad Med Sci, Inst Canc, Beijing 100021, Peoples R China
9.Peking Union Med Coll, Sch Basic Med, Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100021, Peoples R China
10.Sun Yat Sen Univ, Canc Hosp, Guangzhou 510275, Guangdong, Peoples R China
11.Zhejiang Med Univ, Womens Hosp, Hangzhou, Zhejiang, Peoples R China
12.Xinjiang Peoples Hosp, Urumqi, Peoples R China
13.Sichuan Univ, Affiliated Hosp 2, Chengdu 610064, Peoples R China
14.Beijing Univ, Peoples Hosp, Beijing 100871, Peoples R China
15.Jiangxi Women & Childrens Hosp, Nanchang, Peoples R China
16.Hunan Peoples Hosp, Changsha, Hunan, Peoples R China
17.Gansu Women & Childrens Hosp, Lanzhou, Peoples R China
18.Chongqing Canc Hosp, Chongqing, Peoples R China
19.Gulou Hosp, Nanjing, Peoples R China
20.Guangxi Canc Hosp, Nanning, Peoples R China
21.Shenzhen Women & Childrens Hosp, Shenzhen, Peoples R China
22.Kunming Med Coll, Affiliated Hosp 2, Kunming, Peoples R China
23.China Japan Friendship Hosp, Beijing, Peoples R China
24.GlaxoSmithKline Biol, Singapore, Singapore
25.Univ N Carolina, Chapel Hill, NC USA
推荐引用方式
GB/T 7714
Chen, Wen,Zhang, Xun,Molijn, Anco,et al. Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18[J]. CANCER CAUSES &amp; CONTROL,2009,20(9):1705-1713.
APA Chen, Wen.,Zhang, Xun.,Molijn, Anco.,Jenkins, David.,Shi, Ju-Fang.,...&Smith, Jennifer S..(2009).Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18.CANCER CAUSES & CONTROL,20(9),1705-1713.
MLA Chen, Wen,et al."Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18".CANCER CAUSES & CONTROL 20.9(2009):1705-1713.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Chen, Wen]的文章
[Zhang, Xun]的文章
[Molijn, Anco]的文章
百度学术
百度学术中相似的文章
[Chen, Wen]的文章
[Zhang, Xun]的文章
[Molijn, Anco]的文章
必应学术
必应学术中相似的文章
[Chen, Wen]的文章
[Zhang, Xun]的文章
[Molijn, Anco]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。